Macrocure Ltd. (MCUR) saw a big move last session, as the company’s shares fell nearly 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for MCUR as the stock is now up over 21% in the past one-month time frame.
The biotechnology company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
MCUR currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked stock in the same sector is Gilead Sciences Inc. (GILD), holding a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment